4 Results for "

SB243213

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SB243213" in MCE Product Catalog:

Cat. No.: HY-103112B
CAS No.: 200940-22-3
Purity:  99.39%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SB 243213 is an orally active, selective and high-affinity 5-HT2C receptor antagonist with a pKi of 9.37 and a pKb of 9.8 for human 5-HT2C receptor. SB 243213 shows greater than a 100-fold selectivity over a wide range of neurotransmitter receptors, enzymes and ion channels. SB 243213 has improved anxiolytic profile and has the potential for schizophrenia and motor disorders .
loading...
    loading...
Cat. No.: HY-103112
CAS No.: 200940-23-4
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SB 243213 hydrochloride is an orally active, selective and high-affinity 5-HT2C receptor antagonist with a pKi of 9.37 and a pKb of 9.8 for human 5-HT2C receptor. SB 243213 hydrochloride shows greater than a 100-fold selectivity over a wide range of neurotransmitter receptors, enzymes and ion channels. SB 243213 hydrochloride has improved anxiolytic profile and has the potential for schizophrenia and motor disorders .
loading...
    loading...
Cat. No.: HY-103112A
CAS No.: 1780372-25-9
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SB 243213 dihydrochloride is an orally active, selective and high-affinity 5-HT2C receptor antagonist with a pKi of 9.37 and a pKb of 9.8 for human 5-HT2C receptor. SB 243213 dihydrochloride shows greater than a 100-fold selectivity over a wide range of neurotransmitter receptors, enzymes and ion channels. SB 243213 dihydrochloride has improved anxiolytic profile and has the potential for schizophrenia and motor disorders .
loading...
    loading...
Cat. No.: HY-103112BR
CAS No.: 200940-22-3
Research Areas:  

Neurological Disease

SB 243213 (Standard) is the analytical standard of SB 243213 (HY-103112B). This product is intended for research and analytical applications. SB 243213 is an orally active, selective and high-affinity 5-HT2C receptor antagonist with a pKi of 9.37 and a pKb of 9.8 for human 5-HT2C receptor. SB 243213 shows greater than a 100-fold selectivity over a wide range of neurotransmitter receptors, enzymes and ion channels. SB 243213 has improved anxiolytic profile and has the potential for schizophrenia and motor disorders .
loading...
    loading...